—–
Akili Adds Amgen Ventures and M Ventures* to Series B Financing, Increasing Round to $42.4 Million (press release):
“Akili Interactive Labs, Inc. (“Akili”), a digital medicine company developing novel, non-pharmacological therapeutics and diagnostics for cognitive disorders, today announced an $11.9 million expansion of its recent Series B financing. [Read more…] about Akili raises an additional $11.9M; brings Amgen, Merck, Pfizer and Shire to the digital medicine table